Inicio › Miastenia grave › Carolina del Norte
Ensayos clínicos de Miastenia grave en Carolina del Norte
14 estudios sobre Miastenia grave buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
Texto oficial del estudio (inglés)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Velocity Clinical Research, Inc., Raleigh
- Atrium Health Wake Forest Baptist, Winston-Salem
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Fayetteville
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07647510ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- University of North Carolina at Chapel Hill-170 Manning Dr., Chapel Hill
- Duke Early Phase Clinical Research Unit - PPDS, Durham
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- University of North Caroline at Chapel Hill-170 Manning Dr, Chapel Hill
- Duke Early Phase Clinical Research Unit - PPDS, Durham
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07284420A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, New Bern
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- UNC Hospitals - PARENT, Chapel Hill
- Atrium Health Wake Forest Baptist, Winston-Salem
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT06463587Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- The University of North Carolina at Chapel Hill, Chapel Hill
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06414954Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1020, Chapel Hill
- Site Number - 1013, Durham
- Site Number - 1044, Raleigh
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 jul 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Duke University School of Medicine, Durham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of North Carolina Hospitals - Neurology Clinic, Chapel Hill
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 jun 2026 · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Raleigh
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 abr 2026 · NCT07221838Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Chapel Hill
- Clinical Trial Site, Charlotte
- Clinical Trial Site, Durham
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT04202341Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- University of North Carolina at Chapel Hill, Chapel Hill
ReclutandoFase 2/3
Edades de 2 a 18 · Todos los sexos · Actualizado el 18 feb 2026 · NCT04833894The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- Duke University, Durham
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 abr 2025 · NCT05564936De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.